StockDrifts LogoStockDrifts

Foresite Capital Management II 13F Portfolio

Portfolio Manager
Foresite Capital Management Ii, Llc
Performance
0% (N/A)
AUM (13F)
$29.23M
# of Holdings
1
Performance Rank
N/A
Allocation (Top 20)
N/A
Latest filing
Q3 2023

Foresite Capital Management Ii, Llc Holdings Map

Top 1 Foresite Capital Management Ii, Llc Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
TXG
10x Genomics, Inc.
100%708.5K$29.2M
+0.00%(+0)
2022-Q3: 1.75M shares2022-Q4: 1.36M shares2023-Q1: 708.5K shares2023-Q2: 708.5K shares2023-Q3: 708.5K shares2023-09-30

About Foresite Capital Management Ii, Llc’s portfolio

Foresite Capital Management Ii, Llc reports $29.23M in US-listed equity holdings across 1 position in its most recent 13F filing. Its largest disclosed position is TXG (100.0%). Figures reflect the Q3 2023 filing.

Portfolio concentration

Unlock alerts, watchlists & AI chat

Sign up free to track Foresite Capital Management Ii, Llc, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from Foresite Capital Management Ii, Llc’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1594912). View Foresite Capital Management Ii, Llc’s 13F filings on SEC

More 13F analyses

View all